본문 바로가기
KERD
논문KCI 등재

Recent Issues Related to Thyroid Disease in Pregnancy

정재훈
대한갑상선학회 (Korean Thyroid Association)|2020.11|International Journal of Thyroidology|제13권 제2호|pp. 85-94|DOI 10.11106/ijt.2020.13.2.85

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

PregnancyMalformationAutoantibodiesThyrotropinAntithyroid agents
주제분류의학일반

초록

Maternal and fetal complications may occur because of pathologic or immunologic changes during pregnancy. The American Thyroid Association (ATA) suggests an optimal thyroid stimulating hormone (TSH) reference rangeof 0.50-4.00 mU/L in pregnant women. Based on Korean data, the same range may be applied to Korean pregnantwomen. According to the ATA guideline, levothyroxine therapy is recommended for thyroid peroxidase antibody(TPOAb)-positive women with a TSH greater than the pregnancy-specific reference range (approximately ＞4.0mU/L in Korea) and TPOAb-negative women with a TSH ＞10.0 mU/L. The presence of TPOAb may be a signof hypothyroidism due to damage to the thyroid. Because the titer of TPOAb decreases as gestation progresses,its measurement should be performed as early as possible during pregnancy. Although the mechanism is unknown,the association between thyroid autoimmunity and miscarriage/premature delivery is clear. Selenium may reducethe development of postpartum thyroiditis and permanent hypothyroidism; however, routine prescription ofselenium is not recommended as it may increase the risk of type 2 diabetes. According to Korean nationwidedata, birth defects in antithyroid drug (ATD)-exposed offspring in early pregnancy increased by 1.1 to 2.2%compared with non-exposed offspring. Avoidance of ATD in early pregnancy is the best option, otherwise, it ispreferable to switch to propylthiouracil before pregnancy. When methimazole use is unavoidable in earlypregnancy, it is recommended to use less than 5 mg per day.

Abstract

Maternal and fetal complications may occur because of pathologic or immunologic changes during pregnancy. The American Thyroid Association (ATA) suggests an optimal thyroid stimulating hormone (TSH) reference rangeof 0.50-4.00 mU/L in pregnant women. Based on Korean data, the same range may be applied to Korean pregnantwomen. According to the ATA guideline, levothyroxine therapy is recommended for thyroid peroxidase antibody(TPOAb)-positive women with a TSH greater than the pregnancy-specific reference range (approximately ＞4.0mU/L in Korea) and TPOAb-negative women with a TSH ＞10.0 mU/L. The presence of TPOAb may be a signof hypothyroidism due to damage to the thyroid. Because the titer of TPOAb decreases as gestation progresses,its measurement should be performed as early as possible during pregnancy. Although the mechanism is unknown,the association between thyroid autoimmunity and miscarriage/premature delivery is clear. Selenium may reducethe development of postpartum thyroiditis and permanent hypothyroidism; however, routine prescription ofselenium is not recommended as it may increase the risk of type 2 diabetes. According to Korean nationwidedata, birth defects in antithyroid drug (ATD)-exposed offspring in early pregnancy increased by 1.1 to 2.2%compared with non-exposed offspring. Avoidance of ATD in early pregnancy is the best option, otherwise, it ispreferable to switch to propylthiouracil before pregnancy. When methimazole use is unavoidable in earlypregnancy, it is recommended to use less than 5 mg per day.

참고문헌 (49)

  1. Glinoer D, "The regulation of thyroid function in pregnancy : pathways of endocrine adaptation from physiology to pathology", Endocr Rev, 18(3), pp.404~433 (1997)
  2. Glinoer D, "The importance of iodine nutrition during pregnancy", Public Health Nutr, 10(12A), pp.1542~1546 (2007)
  3. Glinoer D, "A randomized trial for the treatment of mild iodine deficiency during pregnancy : maternal and neonatal effects", J Clin Endocrinol Metab, 80(1), pp.258~269 (1995)
  4. De Groot L, "Management of thyroid dysfunction during pregnancy and postpartum : an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 97(8), pp.2543~2565 (2012)
  5. Alexander EK, "2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum", Thyroid, 27(3), pp.315~389 (2017)
  6. Orito Y, "Thyroid function in early pregnancy in Japanese healthy women : relation to urinary iodine excretion, emesis, and fetal and child development", J Clin Endocrinol Metab, 94(5), pp.1683~1688 (2009)
  7. Andersen S, "Reliability of studies of iodine intake and recommendations for number of samples in groups and in individuals", Br J Nutr, 99(4), pp.813~818 (2008)
  8. Konig F, "Ten repeat collections for urinary iodine from spot samples or 24-hour samples are needed to reliably estimate individual iodine status in women", J Nutr, 141(11), pp.2049~2054 (2011)
  9. Cho YY, "Iodine status in healthy pregnant women in Korea : a first report", Eur J Nutr, 55(2), pp.469~475 (2016)
  10. WHO, "Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers" (2007), World Health Organization
  11. 이가희, "임신 산후 갑상선질환의 진단 치료 권고안", International Journal of Thyroidology, 7(1), pp.7~39 (2014), 대한갑상선학회
  12. Vaidya B, "Detection of thyroid dysfunction in early pregnancy : universal screening or targeted high-risk case finding?", J Clin Endocrinol Metab, 92(1), pp.203~207 (2007)
  13. Horacek J, "Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding", Eur J Endocrinol, 163(4), pp.645~650 (2010)
  14. Negro R, "Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy", J Clin Endocrinol Metab, 95(4), pp.1699~1707 (2010)
  15. Laurberg P, "Screening for overt thyroid disease in early pregnancy may be preferable to searching for small aberrations in thyroid function tests", Clin Endocrinol(Oxf), 79(3), pp.297~304 (2013)
  16. Stagnaro-Green A, "Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum", Thyroid, 21(10), pp.1081~1125 (2011)
  17. Li C, "Assessment of thyroid function during first-trimester pregnancy : what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women?", J Clin Endocrinol Metab, 99(1), pp.73~79 (2014)
  18. Marwaha RK, "Establishment of reference range for thyroid hormones in normal pregnant Indian women", BJOG, 115(5), pp.602~606 (2008)
  19. 문희원, "Establishment of Trimester-Specific Reference Intervals for Thyroid Hormones in Korean Pregnant Women", Annals of Laboratory Medicine, 35(2), pp.198~204 (2015), 대한진단검사의학회
  20. Hye Jeong Kim, "Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area", The Korean Journal of Internal Medicine, 33(3), pp.552~560 (2018), 대한내과학회[DOI]
  21. Hollowell JG, "Serum TSH, T(4), and thyroid antibodies in the United States population(1988 to 1994) : National Health and Nutrition Examination Survey(NHANES III)", J Clin Endocrinol Metab, 87(2), pp.489~499 (2002)
  22. 김원구, "Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015", Endocrinology and Metabolism, 32(1), pp.106~114 (2017), 대한내분비학회
  23. Stagnaro-Green A, "A prospective study of lymphocyteinitiated immunosuppression in normal pregnancy : evidence of a T-cell etiology for postpartum thyroid dysfunction", J Clin Endocrinol Metab, 74(3), pp.645~653 (1992)
  24. Shi X, "Optimal and safe upper limits of iodine intake for early pregnancy in iodine-sufficient regions : a cross-sectional study of 7190 pregnant women in China", J Clin Endocrinol Metab, 100(4), pp.1630~1638 (2015)
  25. Glinoer D, "Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders", J Clin Endocrinol Metab, 79(1), pp.197~204 (1994)
  26. Negro R, "Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease : effects on obstetrical complications", J Clin Endocrinol Metab, 91(7), pp.2587~2591 (2006)
  27. Medici M, "Maternal early pregnancy and newborn thyroid hormone parameters : the Generation R study", J Clin Endocrinol Metab, 97(2), pp.646~652 (2012)
  28. De Leo S, "Autoimmune thyroid disease during pregnancy", Lancet Diabetes Endocrinol, 6(7), pp.575~586 (2018)
  29. Liu H, "Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage : a prospective cohort study", Thyroid, 24(11), pp.1642~1649 (2014)
  30. Stagnaro-Green A, "Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies", JAMA, 264(11), pp.1422~1425 (1990)
  31. Thangaratinam S, "Association between thyroid autoantibodies and miscarriage and preterm birth : meta-analysis of evidence", BMJ, 342, pp.d2616~ (2011)
  32. van den Boogaard E, "Significance of(sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy : a systematic review", Hum Reprod Update, 17(5), pp.605~619 (2011)
  33. Mecacci F, "Thyroid autoimmunity and its association with non-organ-specific antibodies and subclinical alterations of thyroid function in women with a history of pregnancy loss or preeclampsia", J Reprod Immunol, 46(1), pp.39~50 (2000)
  34. Kim NY, "Thyroid autoimmunity and its association with cellular and humoral immunity in women with reproductive failures", Am J Reprod Immunol, 65(1), pp.78~87 (2011)
  35. Kwak-Kim JY, "Increased T helper 1cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF", Hum Reprod, 18(4), pp.767~773 (2003)
  36. Konova E, "The role of NK cells in the autoimmune thyroid disease-associated pregnancy loss", Clin Rev Allergy Immunol, 39(3), pp.176~184 (2010)
  37. Toulis KA, "Thyroid autoimmunity and miscarriages : the corpus luteum hypothesis", Med Hypotheses, 73(6), pp.1060~1062 (2009)
  38. Lepoutre T, "Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases", Gynecol Obstet Invest, 74(4), pp.265~273 (2012)
  39. Dhillon-Smith RK, "Levothyroxine in women with thyroid peroxidase antibodies before conception", N Engl J Med, 380(14), pp.1316~1325 (2019)
  40. Vissenberg R, "Effect of levothyroxine on live birth rate in euthyroid women with recurrent miscarriage and TPO antibodies(T4-LIFE study)", Contemp Clin Trials, 44, pp.134~138 (2015)
  41. Stagnaro-Green A, "High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy", J Clin Endocrinol Metab, 96(3), pp.652~657 (2011)
  42. Negro R, "The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies", J Clin Endocrinol Metab, 92(4), pp.1263~1268 (2007)
  43. Mao J, "Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency", Eur J Nutr, 55(1), pp.55~61 (2016)
  44. Stranges S, "Effects of long-term selenium supplementation on the incidence of type 2 diabetes : a randomized trial", Ann Intern Med, 147(4), pp.217~223 (2007)
  45. Rivkees SA, "Ending propylthiouracil-induced liver failure in children", N Engl J Med, 360(15), pp.1574~1575 (2009)
  46. Bahn RS, "The role of propylthiouracil in the management of Graves' disease in adults : report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration", Thyroid, 19(7), pp.673~674 (2009)
  47. Bahn Chair RS, "Hyperthyroidism and other causes of thyrotoxicosis : management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists", Thyroid, 21(6), pp.593~646 (2011)
  48. Andersen SL, "Birth defects after early pregnancy use of antithyroid drugs : a Danish nationwide study", J Clin Endocrinol Metab, 98(11), pp.4373~4381 (2013)
  49. Seo GH, "Antithyroid drugs and congenital malformations : a nationwide Korean cohort study", Ann Intern Med, 168(6), pp.405~413 (2018)

이 간행물의 다른 논문 (14건)

COVID-19 유행 시기의 갑상선질환 관리정현경, 유원상pp. 65-71갑상선유두암의 적절한 수술 범위김완욱pp. 72-78갑상선유두암에서 전이림프절에 대한 적절한 수술 범위권현근, 이병주pp. 79-84Increasing Incidence of Thyroid Carcinoma: Risk Factors and Seeking Approaches for Primary PreventionChristoph Reiners, Daniel I. Branovan, Valentina Drozdpp. 95-110Predictive Risk Factors for Recurrence or Metastasis in Papillary Thyroid Cancer김완욱, Ralph P. Tufano, 박지영, 이지연, 정지윤, 박호용, 정진향pp. 111-117
원문 보기